Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | APEX1 | P27695 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.61 |
| ▸ | RARB | P10826 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8682933 | 1.00 | HTT (1.00) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL10428187 | 1.00 | HTT (1.00) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL10428461 | 1.00 | HTT (1.00) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL8678901 | 1.00 | HTT (1.00) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL1309117 | 1.00 | HTT (1.00) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL9952684 | 1.00 | HTT (1.00) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL11467186 | 0.99 | HTT (0.97) | HTTPOLBAPEX1TDP1TSHR | |
| Hydrochloric Acid SCHEMBL6450158 | 0.99 | HTT (0.97) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL2034725 | 0.98 | HTT (0.97) | HTTPOLBAPEX1TDP1TSHR | |
| SCHEMBL9105115 | 0.96 | HTT (0.92) | HTTPOLBAPEX1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120298932-A1 | METAL COMPLEX, COMPOSITION COMPRISING SAME AND LIGHT-EMITTING ELEMENT USING SAME | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2012-11-29 | — | — | US | disclosed |
| EP-2460788-A1 | METAL COMPLEX, COMPOSITION COMPRISING SAME AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Limited (JP) | 2012-06-06 | — | — | EP | disclosed |
| US-5554706-A | LOW TEMPERATURE LIQUID CRYSTALS | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1996-09-10 | — | — | US | disclosed |
| EP-0695770-A1 | COPOLYMER HAVING LIQUID CRYSTAL GROUP IN THE SIDE CHAIN | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1996-02-07 | — | — | EP | disclosed |
| EP-0536200-B1 | FLUORINE-CONTAINING ACRYLATE AND METHACRYLATE SIDE-CHAIN LIQUID CRYSTAL MONOMERS AND POLYMERS | MINNESOTA MINING & MFG (US) | 1995-10-11 | — | — | EP | disclosed |
| US-5252251-A | Mesomorphic polymer, monomeric mesomorphic compounds, liquid crystal composition and liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1993-10-12 | — | — | US | disclosed |
| EP-0536200-A1 | FLUORINE-CONTAINING ACRYLATE AND METHACRYLATE SIDE-CHAIN LIQUID CRYSTAL MONOMERS AND POLYMERS. | MINNESOTA MINING & MFG (US) | 1993-04-14 | — | — | EP | disclosed |
| EP-0376310-B1 | MESOMORPHIC POLYMER, MONOMERIC MESOMORPHIC COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE | CANON KABUSHIKI KAISHA (JP) | 1993-03-03 | — | — | EP | disclosed |
| US-5087672-A | Lower birefringence and viscosity, increased hydrophobicity | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-02-11 | — | — | US | disclosed |
| WO-1991019773-A1 | FLUORINE-CONTAINING ACRYLATE AND METHACRYLATE SIDE-CHAIN LIQUID CRYSTAL MONOMERS AND POLYMERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-12-26 | — | — | WO | disclosed |
| US-4496734-A | Metabolite | RIKER LABORATORIES, INC. (US) | 1985-01-29 | — | — | US | disclosed |
| US-4491584-A | ANTIARRHYTHMIA AGENTS | RIKER LABORATORIES (US) | 1985-01-01 | — | — | US | disclosed |
| US-4452983-A | N-(2-PIPERIDYLMETHYL)-2,2,2-TRIFLUOROETHOXY)-BENZAMIDE | RIKER LABORATORIES, INC. (US) | 1984-06-05 | — | — | US | disclosed |
| US-4390716-A | INTERMEDIATES FOR ANTIARRHYTHMIC BENZAMIDE COMPOUNDS | RIKER LABORATORIES, INC. (US) | 1983-06-28 | — | — | US | disclosed |
| US-4339587-A | ANTIARRHYTHMIA AGENTS | RIKER LABORATORIES, INC. (US) | 1982-07-13 | — | — | US | disclosed |
| US-4154941-A | ANTIARRHYTHMIC AGENTS | RIKER LABORATORIES, INC. (US) | 1979-05-15 | — | — | US | disclosed |
| US-4097481-A | ANTIARRHYTHMIC AGENTS | RIKER LABORATORIES, INC. (US) | 1978-06-27 | — | — | US | disclosed |
| US-4071524-A | Derivatives of urea | RIKER LABORATORIES, INC. (US) | 1978-01-31 | — | — | US | disclosed |
| US-4013670-A | ANTIARRHYTHMICS | RIKER LABORATORIES, INC. (US) | 1977-03-22 | — | — | US | disclosed |
| US-4005209-A | Antiarrhythmic method utilizing fluoroalkoxy-N-piperidyl and pyridyl benzamides | RIKER LABORATORIES, INC. (US) | 1977-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120298932-A1 | METAL COMPLEX, COMPOSITION COMPRISING SAME AND LIGHT-EMITTING ELEMENT USING SAME | C1S, AP3M1, AP1M1 | HTT 3049/4885POLB 3800/4885APEX1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.